Filip Borgions
Directeur Technique/Scientifique/R&D chez ARGENX SE
Profil
Dr. Filip Borgions is a Global Head-Technical Operations at argenx SE.
Dr. Borgions was previously employed as a Principal by Thrombogenics, Inc. He received his undergraduate degree from Katholieke Universiteit Leuven and a doctorate degree from Katholieke Universiteit Leuven.
Postes actifs de Filip Borgions
| Sociétés | Poste | Début |
|---|---|---|
| ARGENX SE | Directeur Technique/Scientifique/R&D | 01/01/2015 |
Anciens postes connus de Filip Borgions
| Sociétés | Poste | Fin |
|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Corporate Officer/Principal | - |
Formation de Filip Borgions
| Katholieke Universiteit Leuven | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Entreprise privées | 1 |
|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |